Full Breakdown
OpenAI Executive Fidji Simo Takes Medical Leave for POTS Treatment
4/6/2026, 12:08:51 PM
Core Event: Fidji Simo's Medical Leave
Fidji Simo, an executive at OpenAI, is taking a temporary medical leave to treat postural tachycardia syndrome (POTS), as announced in an internal memo to OpenAI staff. Simo, who has been diagnosed with POTS since 2019, will be pursuing treatment and is expected to return in several weeks.
Background on POTS
Postural tachycardia syndrome affects the autonomic nervous system, which regulates involuntary bodily functions such as heart rate and blood pressure. Symptoms of POTS include dizziness, fainting, and a rapid heartbeat, particularly when transitioning from sitting or lying down to standing. The condition is more prevalent among individuals aged 15 to 50, with a higher incidence in women. Factors such as pregnancy, major surgery, and viral illnesses can trigger the onset of POTS.
Key Figures: Fidji Simo
Fidji Simo is not only an executive at OpenAI but also a cofounder of the Complex Disorders Alliance and the Metrodara Foundation, organizations dedicated to researching and finding cures for complex health disorders like POTS. Simo has publicly shared her struggles with the condition, describing experiences of fainting and weakness.
Treatment and Management of POTS
Treatment for POTS primarily focuses on managing blood flow and increasing blood volume. While some medications may provide short-term relief, their long-term effectiveness remains uncertain. Lifestyle modifications, such as increased salt intake and hydration, can also alleviate symptoms. The National Institute of Neurological Disorders and Stroke notes that diagnosing POTS can be challenging, as it often requires a thorough review of medical history and symptom discussion.
Criticism & Opposition: Challenges in Diagnosis
Despite advancements in understanding POTS, the condition is often misdiagnosed. Simo herself experienced a misdiagnosis, with one doctor attributing her symptoms to being a "tired mom." This highlights the ongoing challenges in recognizing and treating POTS effectively, as many patients may face skepticism regarding their symptoms.
Official Statements & Responses
OpenAI's internal memo confirmed Simo's leave for treatment, emphasizing the company's support for her health journey. The memo did not provide specific details on her expected return date but indicated that she would be away for several weeks.
What's Next: Ongoing Research and Awareness
As Simo undergoes treatment, her organizations continue to advocate for research into POTS and similar disorders. The impact of COVID-19 on POTS is also an area of ongoing investigation, as some individuals with long-term COVID have reported developing symptoms associated with the syndrome.
Verbatim Quotes
“I was fainting constantly, I was feeling weak,” — Fidji Simo, OpenAI Executive
"Symptoms of orthostatic intolerance... happen because not enough blood flows back to the heart." — National Institute of Neurological Disorders and Stroke
"Doctors typically begin by reviewing a person's medical history and discussing their symptoms." — National Institute of Neurological Disorders and Stroke
